Yahoo · Oct 27, 2026
What to expect from CONMED’s (CNMD) Q3 earnings
Medical tech company CONMED (NYSE:CNMD) will be reporting earnings this Wednesday after the bell. Here’s what you need to know.
CN
NYSE · CNMD
CONMED Corporation
Healthcare · Medical - Devices
$45.72
Down-$0.53 (-1.15%)
Updated Oct 30, 2026, 1:47 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.23B
- P/E ratio
- 11.17
- Dividend yield
- 1.75%
- 52-week range
- $31.44 – $53.66
- Volume
- 482.19K
- Avg. volume
- 469.39K
Price performance · CNMD
CNMD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
CNMD closed at $45.72 after 21 trading sessions, down 0.46% for the selected period.
- Last close
- $45.72
- Period change
- -0.46%
- Period low
- $44.23
- Period high
- $49.44
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $43.60 | $46.47 | $43.50 | $45.72 | 482.19K |
| Oct 28, 2026 | $47.40 | $48.09 | $45.12 | $45.76 | 610.18K |
| Oct 27, 2026 | $48.09 | $48.09 | $46.53 | $47.20 | 505.95K |
| Oct 26, 2026 | $48.78 | $49.73 | $47.56 | $47.68 | 386.61K |
| Oct 23, 2026 | $49.03 | $49.72 | $48.31 | $49.25 | 343.26K |
| Oct 22, 2026 | $47.38 | $49.56 | $47.38 | $49.44 | 398.58K |
| Oct 21, 2026 | $46.92 | $47.80 | $46.54 | $47.11 | 442.96K |
| Oct 20, 2026 | $45.815 | $48.00 | $45.815 | $47.58 | 440.15K |
| Oct 19, 2026 | $46.49 | $47.06 | $45.89 | $46.05 | 342.34K |
| Oct 16, 2026 | $47.32 | $47.80 | $46.50 | $46.72 | 413.97K |
| Oct 15, 2026 | $45.59 | $47.85 | $44.89 | $47.14 | 401.29K |
| Oct 14, 2026 | $45.23 | $46.59 | $44.53 | $44.93 | 392.39K |
| Oct 13, 2026 | $45.59 | $46.09 | $44.09 | $45.55 | 521.74K |
| Oct 12, 2026 | $44.96 | $45.45 | $44.18 | $45.36 | 515.22K |
| Oct 9, 2026 | $44.89 | $45.66 | $44.145 | $44.42 | 400.45K |
| Oct 8, 2026 | $44.32 | $45.43 | $44.05 | $45.11 | 473.96K |
| Oct 7, 2026 | $44.07 | $44.6425 | $43.97 | $44.23 | 521.29K |
| Oct 6, 2026 | $47.83 | $48.25 | $44.31 | $44.48 | 456.37K |
| Oct 5, 2026 | $46.43 | $47.77 | $46.11 | $47.33 | 343.34K |
| Oct 2, 2026 | $46.88 | $47.06 | $46.1601 | $46.32 | 240.74K |
| Oct 1, 2026 | $46.18 | $46.59 | $45.73 | $45.93 | 222.4K |
Latest CNMD news
The latest Smart Investors Daily articles mentioning CNMD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
CNMD research
Overview
Company profile and research snapshot.
Company profile
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $78.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | Piper Sandler | Neutral | — |
| Jul 30, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jun 29, 2026 | B of A Securities | Underperform | — |
| May 18, 2026 | B of A Securities | Neutral | — |
News briefing
Generated Oct 29, 2026, 9:20 PM
Why Is CNMD Essentially Flat Today?
CONMED Corporation shares are virtually unchanged, down just $0.04 (0.09%), as investors digest upcoming Q3 earnings expectations. The minimal price movement suggests the market is in a holding pattern ahead of the company's earnings announcement, with neither significant bullish nor bearish catalysts driving trading today.
Bottom line: CONMED is holding steady ahead of Q3 earnings, with investors awaiting concrete results to validate the company's operational trajectory. Watch for guidance commentary on demand trends, margin sustainability, and capital spending across hospital systems—these insights will be critical in determining whether the stock breaks out of its current consolidation.
Yahoo · Oct 16, 2026
3 Low-Volatility Stocks with Questionable Fundamentals
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Yahoo · Oct 2, 2026
Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers.
Yahoo · Oct 1, 2026
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
LARGO, Fla., October 01, 2026--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
